• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

科威特阿拉伯人和俄罗斯人PI基因3'侧翼区域的TaqI多态性

TaqI polymorphism in the 3' flanking region of the PI gene among Kuwaiti Arabs and Russians.

作者信息

Samilchuk E, D'Souza B, Voevodin A, Chuchalin A, al-Awadi S

机构信息

Kuwait Medical Genetics Center, Kuwait.

出版信息

Dis Markers. 1997 Apr;13(2):87-92.

PMID:9160183
Abstract

The Taq1 polymorphism in the 3' flanking region of the PI gene has been reported to be associated with chronic obstructive pulmonary disease (COPD). We have studied the frequency of the Taq1 polymorphism in 117 Kuwaiti Arabs and 110 Russians using PCR/RFLP. The frequency of this polymorphism was found to be 0.235 in the Arabs and 0.027 in the Russians. Such a striking difference in allele frequencies could be due to a 'founder effect' in the Kuwaiti population. However: it may also be that this mutation provides a selective advantage, thus accounting for its fixation at a rather high frequency in some populations. Our results suggest that ethnic composition is a very important factor which should be taken into consideration when studying the association of the Taq1 polymorphism with COPD.

摘要

据报道,PI基因3'侧翼区域的Taq1多态性与慢性阻塞性肺疾病(COPD)相关。我们使用聚合酶链反应/限制性片段长度多态性(PCR/RFLP)技术研究了117名科威特阿拉伯人和110名俄罗斯人Taq1多态性的频率。结果发现,该多态性在阿拉伯人中的频率为0.235,在俄罗斯人中为0.027。等位基因频率的这种显著差异可能是由于科威特人群中的“奠基者效应”。然而,也可能是这种突变提供了一种选择优势,从而解释了它在某些人群中以相当高的频率固定下来的原因。我们的结果表明,在研究Taq1多态性与COPD的关联时,种族构成是一个非常重要的因素,应予以考虑。

相似文献

1
TaqI polymorphism in the 3' flanking region of the PI gene among Kuwaiti Arabs and Russians.科威特阿拉伯人和俄罗斯人PI基因3'侧翼区域的TaqI多态性
Dis Markers. 1997 Apr;13(2):87-92.
2
Independent mutations in the flanking sequence of the alpha-1-antitrypsin gene are associated with chronic obstructive airways disease.α-1-抗胰蛋白酶基因侧翼序列中的独立突变与慢性阻塞性气道疾病相关。
Dis Markers. 1990 May-Jun;8(3):151-7.
3
No evidence for an association between the 5-hydroxytryptamine 5-HT2a receptor gene and schizophrenia in Kuwaiti Arabs.在科威特阿拉伯人中,没有证据表明5-羟色胺5-HT2a受体基因与精神分裂症之间存在关联。
Psychiatry Clin Neurosci. 2002 Aug;56(4):465-7. doi: 10.1046/j.1440-1819.2002.01037.x.
4
Lack of an association between candidate gene loci and idiopathic generalized epilepsy in Kuwaiti Arab children.科威特阿拉伯儿童中候选基因位点与特发性全身性癫痫之间无关联。
J Biomed Sci. 2005 Oct;12(5):815-8. doi: 10.1007/s11373-005-9009-y. Epub 2005 Nov 9.
5
Alpha-antitrypsin genotypes in Korean patients with chronic obstructive pulmonary disease.韩国慢性阻塞性肺疾病患者的α-抗胰蛋白酶基因型
Respirology. 2005 Mar;10(2):223-8. doi: 10.1111/j.1440-1843.2005.00693.x.
6
Frequency of the 677 C-->T mutation of the methylenetetrahydrofolate reductase gene among Kuwaiti sickle cell disease patients.科威特镰状细胞病患者中亚甲基四氢叶酸还原酶基因677 C→T突变的频率
Am J Hematol. 2001 Apr;66(4):263-6. doi: 10.1002/ajh.1055.
7
The characterization of a mutation of the 3' flanking sequence of the alpha 1-antitrypsin gene commonly associated with chronic obstructive airways disease.与慢性阻塞性气道疾病相关的α1-抗胰蛋白酶基因3'侧翼序列突变的特征分析。
Eur J Clin Invest. 1992 Feb;22(2):134-7. doi: 10.1111/j.1365-2362.1992.tb01946.x.
8
Alpha 1 antitrypsin polymorphism in the Tunisian population with special reference to pulmonary disease.突尼斯人群中的α1抗胰蛋白酶多态性,特别提及肺部疾病
Pathol Biol (Paris). 2008 May;56(3):106-10. doi: 10.1016/j.patbio.2007.05.003. Epub 2007 Nov 26.
9
Association of gene polymorphisms of tumour necrosis factor-alpha and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing.北京汉族人群中肿瘤坏死因子-α和白细胞介素-13基因多态性与慢性阻塞性肺疾病的相关性
Chin Med J (Engl). 2005 Apr 5;118(7):541-7.
10
Association of the PIM3 allele of the alpha-1-antitrypsin gene with chronic obstructive pulmonary disease.α-1抗胰蛋白酶基因的PIM3等位基因与慢性阻塞性肺疾病的关联。
Clin Biochem. 2005 May;38(5):489-91. doi: 10.1016/j.clinbiochem.2005.01.016.